Literature DB >> 10415104

Inhibition studies on the metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.

K W Yang1, M W Crowder.   

Abstract

In an effort to identify a competitive inhibitor that can be used in future spectroscopic and crystallographic studies and to better understand the interaction of a mercaptoacetic acid-thiolester-containing compound with metallo-beta-lactamase L1 from Stenotrophomonas maltophilia, inhibition studies using two thiol-containing compounds were conducted. N-(2'-Mercaptoethyl)-2-phenylacetamide is a competitive inhibitor of L1 with a K(i) of 50 +/- 3 microM, and this compound is not a time-dependent inactivator of L1. N-Benzylacetyl-d-alanylthioacetic acid is a competitive inhibitor of L1 with a K(i) of 1.6 +/- 0.3 microM. Matrix-assisted laser desorption ionization time-of-flight mass spectrometric studies revealed that 2 mol of mercaptoacetate covalently bind to L1 upon incubation of the enzyme with N-benzylacetyl-d-alanylthioacetic acid; however, this covalently modified enzyme has the same activity as wild-type L1. Last, inhibition studies were used to demonstrate that 4-morpholinoethanesulfonic acid does not inhibit L1, even at concentrations up to 300 mM. This work identifies two possible competitive inhibitors which can be used in future structural studies and further demonstrates inhibitory heterogeneity among the metallo-beta-lactamases. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415104     DOI: 10.1006/abbi.1999.1293

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Docking and scoring of metallo-beta-lactamases inhibitors.

Authors:  Lars Olsen; Ingrid Pettersson; Lars Hemmingsen; Hans-Werner Adolph; Flemming Steen Jørgensen
Journal:  J Comput Aided Mol Des       Date:  2004-04       Impact factor: 3.686

2.  Amino Acid Thioester Derivatives: A Highly Promising Scaffold for the Development of Metallo-β-lactamase L1 Inhibitors.

Authors:  Xiao-Long Liu; Ying Shi; Joon S Kang; Peter Oelschlaeger; Ke-Wu Yang
Journal:  ACS Med Chem Lett       Date:  2015-04-23       Impact factor: 4.345

3.  Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?

Authors:  Peter Oelschlaeger; Ni Ai; Kevin T Duprez; William J Welsh; Jeffrey H Toney
Journal:  J Med Chem       Date:  2010-04-22       Impact factor: 7.446

4.  New β-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-β-lactamases.

Authors:  Ke-Wu Yang; Lei Feng; Shao-Kang Yang; Mahesh Aitha; Alecander E LaCuran; Peter Oelschlaeger; Michael W Crowder
Journal:  Bioorg Med Chem Lett       Date:  2013-09-08       Impact factor: 2.823

5.  Mercaptoacetate thioesters and their hydrolysate mercaptoacetic acids jointly inhibit metallo-β-lactamase L1.

Authors:  Cheng Chen; Yang Xiang; Ya Liu; Xiangdong Hu; Ke-Wu Yang
Journal:  Medchemcomm       Date:  2018-05-17       Impact factor: 3.597

6.  Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.

Authors:  Anne L Carenbauer; James D Garrity; Gopal Periyannan; Robert B Yates; Michael W Crowder
Journal:  BMC Biochem       Date:  2002-02-13       Impact factor: 4.059

7.  An Update on the Status of Potent Inhibitors of Metallo-β-Lactamases.

Authors:  Nazar Ul Islam
Journal:  Sci Pharm       Date:  2013-03-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.